Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 8 studies | 54% ± 22% | |
epithelial cell of proximal tubule | 7 studies | 67% ± 24% | |
hepatocyte | 6 studies | 81% ± 19% | |
epithelial cell | 5 studies | 34% ± 26% | |
endothelial cell | 4 studies | 42% ± 13% | |
mature NK T cell | 3 studies | 42% ± 9% | |
intestinal crypt stem cell | 3 studies | 36% ± 1% | |
cholangiocyte | 3 studies | 56% ± 23% | |
acinar cell | 3 studies | 48% ± 29% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 242772.87 | 226 / 226 | 96% | 2295.14 | 391 / 406 |
pancreas | 100% | 15561.16 | 328 / 328 | 79% | 49.87 | 140 / 178 |
intestine | 97% | 25927.28 | 939 / 966 | 72% | 37.21 | 377 / 527 |
stomach | 92% | 2177.67 | 329 / 359 | 68% | 46.43 | 194 / 286 |
kidney | 100% | 241282.31 | 89 / 89 | 56% | 89.57 | 506 / 901 |
adrenal gland | 100% | 141.70 | 258 / 258 | 11% | 26.04 | 25 / 230 |
spleen | 89% | 218.62 | 215 / 241 | 0% | 0 | 0 / 0 |
esophagus | 58% | 73.55 | 842 / 1445 | 28% | 12.83 | 52 / 183 |
brain | 86% | 63.08 | 2270 / 2642 | 0% | 0.02 | 2 / 705 |
lung | 74% | 50.33 | 429 / 578 | 12% | 7.11 | 135 / 1155 |
heart | 86% | 64.13 | 739 / 861 | 0% | 0 | 0 / 0 |
ovary | 79% | 48.35 | 142 / 180 | 0% | 0.05 | 1 / 430 |
uterus | 68% | 49.89 | 115 / 170 | 3% | 5.73 | 13 / 459 |
prostate | 63% | 38.69 | 155 / 245 | 1% | 0.04 | 4 / 502 |
adipose | 57% | 82.26 | 682 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 54% | 34.23 | 718 / 1335 | 0% | 0 | 0 / 0 |
breast | 52% | 72.16 | 237 / 459 | 1% | 0.47 | 7 / 1118 |
thymus | 50% | 30.19 | 324 / 653 | 1% | 0.08 | 6 / 605 |
peripheral blood | 50% | 471.91 | 467 / 929 | 0% | 0 | 0 / 0 |
bladder | 29% | 8.52 | 6 / 21 | 21% | 6.81 | 106 / 504 |
muscle | 45% | 22.04 | 362 / 803 | 0% | 0 | 0 / 0 |
skin | 34% | 28.62 | 616 / 1809 | 1% | 0.22 | 6 / 472 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.15 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.26 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032781 | Biological process | positive regulation of ATP-dependent activity |
GO_0006096 | Biological process | glycolytic process |
GO_0006000 | Biological process | fructose metabolic process |
GO_0006116 | Biological process | NADH oxidation |
GO_0061624 | Biological process | fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate |
GO_0030388 | Biological process | fructose 1,6-bisphosphate metabolic process |
GO_0006094 | Biological process | gluconeogenesis |
GO_0070072 | Biological process | vacuolar proton-transporting V-type ATPase complex assembly |
GO_1905856 | Biological process | negative regulation of pentose-phosphate shunt |
GO_0034451 | Cellular component | centriolar satellite |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0004332 | Molecular function | fructose-bisphosphate aldolase activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0061609 | Molecular function | fructose-1-phosphate aldolase activity |
GO_0051117 | Molecular function | ATPase binding |
GO_0070061 | Molecular function | fructose binding |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ALDOB |
Protein name | Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase) Fructose-bisphosphate aldolase (EC 4.1.2.13) |
Synonyms | ALDB |
Description | FUNCTION: Catalyzes the aldol cleavage of fructose 1,6-biphosphate to form two triosephosphates dihydroxyacetone phosphate and D-glyceraldehyde 3-phosphate in glycolysis as well as the reverse stereospecific aldol addition reaction in gluconeogenesis. In fructolysis, metabolizes fructose 1-phosphate derived from the phosphorylation of dietary fructose by fructokinase into dihydroxyacetone phosphate and D-glyceraldehyde . Acts as an adapter independently of its enzymatic activity, exerts a tumor suppressor role by stabilizing the ternary complex with G6PD and TP53 to inhibit G6PD activity and keep oxidative pentose phosphate metabolism in check . . |
Accessions | ENST00000648758.1 ENST00000649902.1 A0A3B3ITZ0 P05062 ENST00000647789.2 ENST00000648064.1 A0A3B3IS80 ENST00000648423.1 |